NFKB1 and breast cancer: To investigate the biological effect of BA, a potent inhibitor of the NF-κB signaling pathway in BC cells, the MTT assay was conducted to evaluate the viability of BA-treated MDA-MB-231, MDA-MB-453, and 4T1 cells.